| As you may have noticed, on June 1st the DEA recently made effective the electronic prescribing of controlled substances. This is great news for the entire Health IT industry and OA Systems applauds the DEA for taking these much anticipated steps. This will definitely help overcome one of the major hurdles for e-prescribing. However, because of the complexity of the criteria set forth by the DEA for certification of both prescriber and pharmacy applications, it may take a while before the industry actually sees the electronic transmission of controlled substances.
We at OA Systems are currently exploring what needs to be altered in RxCure, our patented e-prescribing software, in order to allow for the electronic transmission of controlled substances. Because these changes may take some time, we cannot determine when you will be able to prescribe controlled substances electronically through RxCure. However, we will keep you updated through our communication streams such as our newsletter and blog. Thank You for your understanding. If you have any questions, please feel free to contact us. For further information, please see FAQs from the DEA and Surescripts Statement on DEA Interim Final Rule. |
|


